Acrx stock forecast.

Stock Price Forecast The 5 analysts offering 12-month price forecasts for BioXcel Therapeutics Inc have a median target of 11.00, with a high estimate of 18.00 and a low estimate of 4.00.

Acrx stock forecast. Things To Know About Acrx stock forecast.

AcelRx Pharma Announces 5.34M Share Private Placement at $1.36/sh. AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ("AcelRx" or the "Company"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use... Investing.com.ACRX Stock Analysis Overview What this means: InvestorsObserver gives Acelrx Pharmaceutica (ACRX) an overall rank of 35, which is below average. Acelrx …Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Athersys Inc have a median target of 5.50, with a high estimate of 5.50 and a low estimate of 5.50. The median estimate ...Investors need to pay close attention to AcelRx (ACRX) stock based on the movements in the options market lately.Nov 3, 2021 · Cash Ratio forecast for AcelRx Pharmaceuticals (ACRX) stock. Annual Cash Ratio forecast for AcelRx Pharmaceuticals stock for 2021 is 1.08299256789893. It is increase 0.39% from the last annual Cash Ratio report of 1.07883329659834. Annual Cash Ratio forecast for 2022 is 1.07667132533243, and 2023 is 1.07669258943835.

May 15, 2023 · Earnings announcement* for ACRX: May 15, 2023. AcelRx Pharmaceuticals, Inc. is estimated to report earnings on 05/15/2023. The upcoming earnings date is derived from an algorithm based on a ... Weather forecasts are essential tools for planning our daily activities, especially when it comes to the next 10 days. Understanding a weather 10 day forecast can help us make informed decisions about outdoor events, travel plans, or even w...

Get a real-time Alaunos Therapeutics, Inc. (TCRT) stock price quote with breaking news, financials, statistics, charts and more. Get a real-time Alaunos ... The 12-month stock price forecast is $3.0, which is an increase of 4,431.72% from the latest price. Price Target. $3.0 (4,431.72% upside) Analyst Consensus: Hold. Stock Forecasts ...

Earnings announcement* for ACRX: May 15, 2023. AcelRx Pharmaceuticals, Inc. is estimated to report earnings on 05/15/2023. The upcoming earnings date is derived from an algorithm based on a ...ACRX | Complete AcelRx Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.ACRX Stock Analysis Overview What this means: InvestorsObserver gives Acelrx Pharmaceutica (ACRX) an overall rank of 35, which is below average. Acelrx …Are you tired of spending countless hours manually tracking your inventory? Are you looking for a way to improve your decision making and forecasting processes? Look no further than a free inventory tracking template.

Find the latest AcelRx Pharmaceuticals, Inc. (ACRX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.

When should I take profit in Acelrx Pharmaceuticals stock? Buy or sell stock? Will ACRX stock price go up? What are analysts’ forecasts for ACRX stock? …

AcelRx Pharmaceuticals ( NASDAQ: ACRX) is scheduled to announce Q1 earnings results on Wednesday, May 10th, after market close. The consensus EPS Estimate is -$0.80 and the consensus Revenue ...Analyst Forecast. According to 7 analysts, the average rating for APLD stock is "Strong Buy." The 12-month stock price forecast is $14.21, which is an increase of 204.28% from the latest price.Find the latest AcelRx Pharmaceuticals, Inc. (ACRX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.acrx stock forecast zacks. Stock Price Forecast. Horton Inc on Wednesday forecast first-quarter revenue below estimates and said it expects home prices to d… Friday, November 11, 2022 Edit. Older Posts Home. Subscribe to: …ACRX Business Overview. ACRX is a pharmaceutical company operating in the space of supervised medical settings, i.e. hospitals, ASCs (Ambulatory Surgical Centers), and procedural suites, such as ...

Dec 1, 2023 · View AcelRx Pharmaceuticals, Inc ACRX investment & stock information. Get the latest AcelRx Pharmaceuticals, Inc ACRX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. 3.91%. $84.57M. SRNEQ | Complete Sorrento Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Dec 31, 2021 · ACRX Stock Forecast. While there’s much to be desired from the market after this year, analysts remain bullish. Most recently, Cantor Fitzgerald adjusted its rating to $4 but maintained an Overweight rating. Based on current trading levels, that target sits 615% higher right now. Stock Price Forecast The 1 analysts offering 12-month price forecasts for Iterum Therapeutics PLC have a median target of 15.00, with a high estimate of 15.00 and a low estimate of 15.00. 5 equities research analysts have issued 1 year price targets for Hanesbrands' stock. Their HBI share price targets range from $5.00 to $7.00. On average, they expect the company's stock price to reach $5.75 in the next year. This suggests a possible upside of 56.7% from the stock's current price.

Find real-time SPRO - Spero Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.1 Wall Street research analysts have issued 1-year price objectives for Akari Therapeutics' stock. Their AKTX share price targets range from $30.00 to $30.00. On average, they predict the company's stock price to reach $30.00 in the next year. This suggests a possible upside of 906.7% from the stock's current price.

What this means: InvestorsObserver gives Acelrx Pharmaceutica (ACRX) an overall rank of 35, which is below average. Acelrx Pharmaceutica is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 35 means that 65% of stocks appear more favorable to our system.Stock Price Forecast The 1 analysts offering 12-month price forecasts for Iterum Therapeutics PLC have a median target of 15.00, with a high estimate of 15.00 and a low estimate of 15.00.Stable Share Price: ACRX is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 13% a week. Volatility Over Time : ACRX's weekly …Nov 24, 2023 · AcelRx Pharmaceuticals, Inc. (ACRX) share price prediction for 2023, 2024, 2025, 2026 and 2027. ACRX one year forecast. Acelrx Pharmaceuticals stock monthly and ... Nov 29, 2023 · The Inpixon stock price gained 1.45% on the last trading day (Wednesday, 29th Nov 2023), rising from $0.0621 to $0.0630. During the last trading day the stock fluctuated 6.05% from a day low at $0.0612 to a day high of $0.0649. The price has fallen in 6 of the last 10 days and is down by -11.89% for this period. AcelRx Pharmaceuticals, Inc. (ACRX) share price prediction for 2023, 2024, 2025, 2026 and 2027. ACRX one year forecast. Acelrx Pharmaceuticals stock monthly and ...Based on 7 Wall Street analysts offering 12 month price targets for Applied Digital Corporation in the last 3 months. The average price target is $15.25 with a high forecast of $19.00 and a low forecast of $12.00.The average price target represents a 240.40% change from the last price of $4.48.AcelRx Pharmaceuticals last issued its earnings data on November 8th, 2023. The specialty pharmaceutical company reported ($0.08) EPS for the quarter, beating analysts' consensus estimates of ($0.29) by $0.21. The company earned $0.12 million during the quarter. AcelRx Pharmaceuticals has generated ($2.23) earnings per share over the last year ...Nov 29, 2023 · The AcelRx Pharmaceuticals stock price gained 3.66% on the last trading day (Wednesday, 15th Nov 2023), rising from $0.464 to $0.481. During the last trading day the stock fluctuated 11.04% from a day low at $0.450 to a day high of $0.500. The price has fallen in 6 of the last 10 days and is down by -9.09% for this period.

Heading out for an outdoor adventure? Whether you’re planning a picnic, a hiking trip, or a beach day, one essential tool you need in your arsenal is a detailed weather 10 day forecast.

View the latest AcelRx Pharmaceuticals Inc. (ACRX) stock price, news, historical charts, analyst ratings and financial information from WSJ.

5. Next. From AI system, total return is 2366.52% from 4098 forecasts. See more long term and short term forecasts for your favorite stock. With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.Which healthcare penny stocks should the risk-tolerant crowd have on their radar right now? AcelRx Pharmaceuticals ( ACRX 3.95%) and Sundial Growers ( SNDL 4.89%) are two potential diamonds in the ...Find real-time ITRM - Iterum Therapeutics PLC stock quotes, company profile, news and forecasts from CNN Business. Find real-time SPRO - Spero Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.AcelRx Pharmaceuticals, Inc. 05 Apr, 2023, 08:30 ET. In connection with closing, AcelRx received approximately $2.7 million from Alora Pharmaceuticals and Aguettant. AcelRx announces full ...AcelRx Pharmaceuticals, Inc. Common Stock (ACRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

AcelRx Pharmaceuticals ( NASDAQ: ACRX) is scheduled to announce Q1 earnings results on Wednesday, May 10th, after market close. The consensus EPS Estimate is -$0.80 and the consensus Revenue ...Nov 29, 2023 · Iterum Therapeutics plc (NASDAQ:ITRM) released its quarterly earnings results on Friday, November, 12th. The company reported $0.30 EPS for the quarter, missing the consensus estimate of $1.80 by $1.50. During the same period last year, the company earned ($5.10) EPS. View the latest news, buy/sell ratings, SEC filings and insider transactions ... Get the latest Citius Pharmaceuticals Inc (CTXR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Based on 7 Wall Street analysts offering 12 month price targets for Applied Digital Corporation in the last 3 months. The average price target is $15.25 with a high forecast of $19.00 and a low forecast of $12.00. Instagram:https://instagram. palladium price vs goldretire on 3 millionrent a house or buy a housecheap options to buy Acelrx Pharmaceutica (ACRX) $0.67 0.07 (9.73%) 16:00 EDT ACRX Stock Quote Delayed 30 Minutes.Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Marker Therapeutics Inc have a median target of 40.00, with a high estimate of 40.00 and a low estimate of 40.00. The ... cost of palladium vs goldprfrx Sep 14, 2023 · ACRX stock forecast Our latest prediction for Acelrx Pharmaceuticals Inc's stock price was made on the Sept. 14, 2023 when the stock price was at 0.88$ . In the short term (2weeks), ACRX's stock price should underperform the market by -3.79% . Dec 1, 2023 · AcelRx Pharmaceuticals last issued its earnings data on November 8th, 2023. The specialty pharmaceutical company reported ($0.08) EPS for the quarter, beating analysts' consensus estimates of ($0.29) by $0.21. The company earned $0.12 million during the quarter. AcelRx Pharmaceuticals has generated ($2.23) earnings per share over the last year ... new hampshire mortgage companies AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. AcelRx's lead product candidate, Niyad is a lyophilized formulation of nafamostat and is currently being studied under an investigational device exemption, or IDE ...Stock Price Forecast. The 3 analysts offering 12-month price forecasts for KALA BIO Inc have a median target of 27.00, with a high estimate of 39.00 and a low estimate of 24.00. The median ...ACRX Stock : USD 1.76 0.08 4.35% ... However, it does not forecast the overall direction of its price. In a nutshell, if AcelRx Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, ...